Clare Cutland to South Africa
This is a "connection" page, showing publications Clare Cutland has written about South Africa.
Connection Strength
1,223
-
Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S85-S89.
Score: 0,097
-
Obstetric and neonatal outcomes in South Africa. Vaccine. 2024 Feb 27; 42(6):1352-1362.
Score: 0,090
-
Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions. Vaccine. 2019 05 16; 37(22):2967-2974.
Score: 0,065
-
Causes of stillbirths among women from South Africa: a prospective, observational study. Lancet Glob Health. 2019 04; 7(4):e503-e512.
Score: 0,064
-
Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country. Vaccine. 2015 Nov 25; 33(47):6406-12.
Score: 0,050
-
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
Score: 0,049
-
Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics. 2012 Sep; 130(3):e581-90.
Score: 0,041
-
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009 Dec 05; 374(9705):1909-16.
Score: 0,033
-
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study. Expert Rev Vaccines. 2025 Dec; 24(1):121-127.
Score: 0,024
-
Importance of nosocomial respiratory syncytial virus infections in an African setting. Trop Med Int Health. 2004 Apr; 9(4):491-8.
Score: 0,023
-
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005). Vaccine. 2023 05 26; 41(23):3486-3492.
Score: 0,021
-
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial. Lancet Child Adolesc Health. 2023 05; 7(5):326-335.
Score: 0,021
-
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Lancet Infect Dis. 2023 03; 23(3):295-306.
Score: 0,021
-
Vitamin D Deficiency and Its Association with Iron Deficiency in African Children. Nutrients. 2022 Mar 25; 14(7).
Score: 0,020
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers in South Africa: A Longitudinal Cohort Study. Clin Infect Dis. 2021 11 16; 73(10):1896-1900.
Score: 0,019
-
Incidence of febrile seizures and associated factors in children in Soweto, South Africa. S Afr Med J. 2021 Aug 02; 111(8):796-802.
Score: 0,019
-
Prevalence and predictors of vitamin D deficiency in young African children. BMC Med. 2021 05 20; 19(1):115.
Score: 0,019
-
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 05 20; 384(20):1885-1898.
Score: 0,018
-
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Rev Vaccines. 2020 12; 19(12):1177-1189.
Score: 0,018
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
Score: 0,018
-
Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa. Vaccine. 2020 09 22; 38(41):6478-6483.
Score: 0,018
-
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial. Lancet Infect Dis. 2020 12; 20(12):1426-1436.
Score: 0,018
-
Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials. Lancet Respir Med. 2020 06; 8(6):597-608.
Score: 0,017
-
Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 2020 02 28; 38(10):2350-2360.
Score: 0,017
-
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial. Lancet HIV. 2020 02; 7(2):e91-e103.
Score: 0,017
-
Rubella seroprevalence in pregnant women living with and without HIV in Soweto, South Africa. Int J Infect Dis. 2020 Feb; 91:255-260.
Score: 0,017
-
Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study. Clin Microbiol Infect. 2020 Apr; 26(4):515.e1-515.e4.
Score: 0,017
-
Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Clin Infect Dis. 2019 10 30; 69(10):1789-1796.
Score: 0,017
-
An Observational Pilot Study Evaluating the Utility of Minimally Invasive Tissue Sampling to Determine the Cause of Stillbirths in South African Women. Clin Infect Dis. 2019 10 09; 69(Suppl 4):S342-S350.
Score: 0,017
-
Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. J Infect Dis. 2019 09 26; 220(9):1529-1538.
Score: 0,017
-
Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa. PLoS One. 2019; 14(4):e0214077.
Score: 0,016
-
Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study. Clin Infect Dis. 2018 05 17; 66(11):1658-1665.
Score: 0,015
-
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial. Expert Rev Vaccines. 2017 06; 16(6):641-656.
Score: 0,014
-
Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine (Baltimore). 2017 Jan; 96(2):e5881.
Score: 0,014
-
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS One. 2016; 11(12):e0169101.
Score: 0,014
-
Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S174-S180.
Score: 0,014
-
Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatr. 2016 09 01; 170(9):840-7.
Score: 0,013
-
Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial. Expert Rev Vaccines. 2016 08; 15(8):1055-62.
Score: 0,013
-
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016 08; 16(8):923-34.
Score: 0,013
-
Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology. PLoS One. 2016; 11(4):e0152524.
Score: 0,013
-
Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
Score: 0,013
-
Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South African Children. Pediatr Infect Dis J. 2015 Jul; 34(7):753-60.
Score: 0,012
-
Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One. 2015; 10(4):e0123014.
Score: 0,012
-
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 04; 371(10):918-31.
Score: 0,012
-
Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy. PLoS One. 2014; 9(6):e98778.
Score: 0,012
-
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014 Apr 07; 32(17):1954-63.
Score: 0,011
-
Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants. Pediatr Infect Dis J. 2013 Aug; 32(8):889-97.
Score: 0,011
-
Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B Streptococcus in vaginal and rectal swabs from pregnant women in South Africa. J Clin Microbiol. 2013 Aug; 51(8):2515-9.
Score: 0,011
-
Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J. 2013 May; 32(5):e192-205.
Score: 0,011
-
Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS. 2013 Jan 28; 27(3):369-79.
Score: 0,010
-
Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol. 2013 Feb; 62(Pt 2):249-253.
Score: 0,010
-
Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa. Pediatr Infect Dis J. 2012 Aug; 31(8):821-6.
Score: 0,010
-
Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011 Apr; 30(4):e68-74.
Score: 0,009
-
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011 Feb; 101(2):126-31.
Score: 0,009
-
Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis. 2011 Jan 01; 52(1):128-37.
Score: 0,009
-
Seasonality, incidence, and repeat human metapneumovirus lower respiratory tract infections in an area with a high prevalence of human immunodeficiency virus type-1 infection. Pediatr Infect Dis J. 2007 Aug; 26(8):693-9.
Score: 0,007
-
Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Virol. 2006 Jul; 36(3):215-21.
Score: 0,007
-
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005 May 15; 40(10):1511-8.
Score: 0,006